Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c755c255f2362ded898e32cb6963dfcd http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e1dec52146eb8deb7bc37650e83c7200 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-13 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-39 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2121-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-748 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-81 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-75 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-81 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-75 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-748 |
filingDate |
2019-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2021-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d4cab7186767490af9ad1dc3f24ae963 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_24a388b8f5a856129a9c1a6ed1f55574 |
publicationDate |
2021-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-10953063-B2 |
titleOfInvention |
Method of treating select cancers using timed administration of plant extract from species Physalis pubescens and Hedyotis diffusa willd |
abstract |
A multi time-phase treatment for one of a range of maladies. A dosage form is administered in a first dosage of a therapeutic effective amount of a first plant concentrate or one of its physiological acceptable forms. A dosage form is administered in a second dosage of a therapeutic effective amount of a second plant concentrate or one of its physiological acceptable forms. The first dosage is applied at a first time-phase and the second dosage is applied at a second time-phase spaced from the first time-phase. A combination of the first and second dosage forms administered in at least the first and second time-phases assist in treatment of abnormal cells for treatment for one of the range of maladies. |
priorityDate |
2018-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |